DOSING REGIMEN OF ANTI-TIGIT ANTIBODY FOR TREATMENT OF CANCER | Patent Publication Number 20210403557
US 20210403557 A1Publication DateDec 30, 2021
Original AssigneeMerck & Co. Inc.
Current AssigneeMerck Sharp & Dohme
Inventor/ApplicantsElliot K. Chartash
Zhen Zeng
Mingmei Cai
Jane Anne Healy
Mallika Lala
Kapil Mayawala
Tommy Ruosi Li
Raluca Andreia Predoiu
Sybil M.G. Williams
Zhen Zeng
Mingmei Cai
Jane Anne Healy
Mallika Lala
Kapil Mayawala
Tommy Ruosi Li
Raluca Andreia Predoiu
Sybil M.G. Williams
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.